Abstract
A sensitive and specific LC–MS-MS method is described for the simultaneous quantification of risperidone and 9-hydroxyrisperidone in human plasma. After extraction with tert-butyl methyl ether, plasma samples were separated on an Atlantis HILIC Silica C18 column (4.6 × 150 mm, 5 μm)with a mobile phase of ammonium formate buffer (10 mM, pH 4.0)/acetonitrile (40/60, v/v). Detection was by MS-MS. The method was fully validated according to the accuracy profile theory. It is based on β-expectation tolerance interval for the total measurement error which includes trueness and intermediate precision. The measurement uncertainty derived from β-expectation tolerance interval was estimated at each of the validation standards. The linearity fitted well over the range of 0.11–26.75 ng mL−1 for risperidone with an LLOQ of 0.11 ng mL−1, and for 9-hydroxyrisperidone, at a range of 0.15–37.8 ng mL−1 with an LLOQ of 0.15 ng mL−1. The intra- and inter-batch precision of risperidone were <5.71 and 8.22%, respectively. For 9-hydroxyrisperidone, the data were 5.78 and 6.48%. The recoveries were 88.78% (risperidone) and 70.35% (9-hydroxyrisperidone). The developed method was applied to a pharmacokinetic study of risperidone.
Similar content being viewed by others
References
Leysen JE, Gommeren W, Eens A, de Courcelles D, Stoof JC, Janssen PA (1988) J Pharmacol Exp Ther 247:661–670
Olesen OV, Licht RW, Thomsen E, Bruun T, Viftrup JE, Linnet K (1998) Ther Drug Monit 20:380–384
Kirschbaum KM, Finger S, Vogel F, Burger R, Gerlach M, Riederer P, Hiemke C (2008) Chromatographia 67:321
Frahnert C, Rao ML, Grasmader K (2003) J Chromatogr B 794:35–47
LLerena A, Berecz R, Dorado P, de la Garza CS, Norberto MJ, Caceres M, Gutierrez JR (2003) J Chromatogr B 783:213–219
Nagasaki T, Ohkubo T, Sugawara K, Yasui N, Furukor H, Kaneko S (1999) J Pharm Biomed Anal 19:595–601
Avenoso A, Facciola G, Salemi M, Spina E (2000) J Chromatogr B Biomed Sci Appl 746(2):173–181
Titier K, Bouchet S, Péhourcq F, Moore N, Molimard M (2003) J Chromatogr B 788:179–185
Raggi MA, Bugamelli F, Sabbioni C, Saracino MA, Petio C (2005) J Sep Sci 28:245–250
Muscatello MR, Pacetti M, Cacciola M, Torre DL, Zoccali R, Arrigo CD, Migliardi G, Spina E (2005) Epilepsia 46:771–774
Olesen OV, Linnet K (1997) J Chromatogr B 698(1–2):209–216
Schatz DS, Saria A (2000) Pharmacology 60:51–56
Aravagiri M, Marder SR, Van Putten T, Midha KK (1993) J Pharm Sci 82:447–449
Su FL, Zhou ZL, Li HD (2006) Chin J Pharm Anal 26:207–211
Zhou ZL, Li X, Peng HY, Yu XY, Yang M, Su FL (2006) Acta Pharmacol Sin 27:381–386
Kratzsch C, Peters FT, Kraemer T, Weber AA, Maurer HH (2003) J Mass Spectrom 38:283–295
Zhou ZL, Li X, Li KY, Xie ZH, Cheng ZN, Peng WX (2004) J Chromatogr B 802:257–262
Jiao Z, Yu YQ, Zhang L, Li ZD, Shi XJ, Zhong MK (2006) Chin Pharm J 41(5):384–387
Moody DE, Laycock JD, Huang W, Foltz RL (2004) J Anal Toxicol 28:494–497
Huang MZ, Shentu JZ, Chen JC, Liu J, Zhou HL (2008) J Zhejiang Univ Sci B 9:114–120
McClean S, O’Kane EJ, Smyth WF (2000) J Chromatogr B 740:141–157
Flarakos J, Luo W, Aman M, Svinarov D, Gerber N, Vouros P (2004) J Chromatogr A 1026:175–183
Bhatt J, Subbaiah G, Singh S (2006) Rapid Commun Mass Spectrom 20:2109–2114
Wen YG, Liao RF, Zeng ZP, Zhang M (2007) J Guangdong College Pharm 23:528–530
FDA Guidance for Industry (2001) Bioanalytical method validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Website: http://www.fda.gov/cder/guidance/index.htm
Burns M (2004) Trends Anal Chem 23(5):393–398
Marini RD, Servais AC, Rozet E, Chiap P, Boulanger B, Rudaz S et al (2006) J Chromatogr A 1120:102–111
Ph Hubert, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Chiap P, Cohen N et al (2003) STP Pharma Pratiques 13:101–138
Ph Hubert, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Chiap P, Cohen N et al (2004) J Pharm Biomed Anal 36:579–586
Rozet E, Morello R, Lecomte F, Martin GB, Chiap P, Crommen J et al (2006) J Chromatogr B 844:251–260
Feinberg M, Laurentie M (2006) Accred Qual Assur 11:3–9
Cavalier E, Rozet E, Dubois N, Charlier C, Hubert Ph, Chapelle JP et al (2008) Clin Chim Acta 396:80–85
Hubert Ph, Nguyen-Huu JJ, Boulanger B, Chapuzet E, Cohen N, Compagnon PA et al (2008) J Pharm Biomed Anal 48:760–771
Marini RD, Chiap P, Boulanger B, Rudaz S, Rozet E, Crommen J et al (2006) Talanta 68:1166–1175
Feinberg M, Boulanger B, Dewe W, Hubert Ph (2004) Anal Bioanal Chem 380:502–514
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, X., Zhao, X., Zhang, C. et al. Accuracy Profile Theory for the Validation of an LC–MS-MS Method for the Determination of Risperidone and 9-Hydroxyrisperidone in Human Plasma. Chroma 71, 1015–1023 (2010). https://doi.org/10.1365/s10337-010-1580-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-010-1580-3